Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Biology and Environment (13)
- Clean Energy (29)
- Fusion and Fission (20)
- Fusion Energy (4)
- Isotopes (3)
- Materials (28)
- Materials for Computing (3)
- National Security (10)
- Neutron Science (10)
- Nuclear Science and Technology (16)
- Quantum information Science (2)
- Supercomputing (26)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.